Proton pump inhibitor use increases mortality and hepatic decompensation in liver cirrhosis

BACKGROUND: Proton pump inhibitors (PPIs) are widely prescribed, often without clear indications. There are conflicting data on its association with mortality risk and hepatic decompensation in cirrhotic patients. Furthermore, PPI users and PPI exposure in some studies have been poorly defined with...

Descripción completa

Detalles Bibliográficos
Autores principales: De Roza, Marianne Anastasia, Kai, Lim, Kam, Jia Wen, Chan, Yiong Huak, Kwek, Andrew, Ang, Tiing Leong, Hsiang, John Chen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2019
Materias:
Retrospective Cohort Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6737311/
https://www.ncbi.nlm.nih.gov/pubmed/31543684
http://dx.doi.org/10.3748/wjg.v25.i33.4933

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6737311/
https://www.ncbi.nlm.nih.gov/pubmed/31543684
http://dx.doi.org/10.3748/wjg.v25.i33.4933

Ejemplares similares